Abstract:BackgroundSpinal cord ischemia-reperfusion (I/R) involves two-phase injury, including an initial acute ischemic insult and subsequent inflammatory reperfusion injury, resulting in blood-spinal cord barrier (BSCB) dysfunction involving the TLR4 pathway. However, the correlation between TLR4/MyD88-dependent and TLR4/TRIF-dependent pathways in BSCB dysfunction is not fully understood. The aim of this study is to characterize inflammatory responses in spinal cord I/R and the events that define its clinical progression with delayed neurological deficits, supporting a bimodal mechanism of injury.MethodsRats were intrathecally pretreated with TAK-242, MyD88 inhibitory peptide, or Resveratrol at a 12 h interval for 3 days before undergoing 14-minute occlusion of aortic arch. Evan’s Blue (EB) extravasation and water content were detected at 6, 12, 18, 24, 36, 48, and 72 h after reperfusion. EB extravasation, water content, and NF-κB activation were increased with time after reperfusion, suggesting a bimodal distribution, as maximal increasing were detected at both 12 and 48 h after reperfusion. The changes were directly proportional to TLR4 levels determined by Western blot. Double-labeled immunohistochemical analysis was also used to detect the relationship between different cell types of BSCB with TLR4. Furthermore, NF-κB and IL-1β were analyzed at 12 and 48 h to identify the correlation between MyD88-dependent and TRIF-dependent pathways.ResultsRats without functional TLR4 and MyD88 attenuated BSCB leakage and inflammatory responses at 12 h, suggesting the ischemic event was largely mediated by MyD88-dependent pathway. Similar protective effects observed in rats with depleted TLR4, MyD88, and TRIF receptor at 48 h infer that the ongoing inflammation which occurred in late phase was mainly initiated by TRIF-dependent pathway and such inflammatory response could be further amplified by MyD88-dependent pathway. Additionally, microglia appeared to play a major role in early phase of inflammation after I/R injury, while in late responding phase both microglia and astrocytes were necessary.ConclusionsThese findings indicate the relevance of TLR4/MyD88-dependent and TLR4/TRIF-dependent pathways in bimodal phases of inflammatory responses after I/R injury, corresponding with the clinical progression of injury and delayed onset of symptoms. The clinical usage of TLR4 signaling inhibitors at different phases may be a therapeutic option for the prevention of delayed injury.

TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion.

Toll-like Receptor-4 Pathway As a Possible Molecular Mechanism for Brain Injuries after Subarachnoid Hemorrhage

Disruption of Nrf2 Enhances Upregulation of Nuclear Factor-κB Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule-1 in the Brain after Traumatic Brain Injury

Role of Toll-like receptor mediated signaling in traumatic brain injury

Expression of Toll Like Receptor 4 in Injured Brain Tissue after Traumatic Brain Injury

Toll-like Receptor and Its Roles in Myocardial Ischemic/reperfusion Injury

Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage

TLR 2 / TLR 4 Heterodimer mediates Inflammatory Injury in Intracerebral Hemorrhage Running head : TLR 2 / TLR 4 Heterodimer in Intracerebral Hemorrhage

Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury.

Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice.

Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats

Brain Recovery Mediated by Toll-Like Receptor 4 in Rats after Intracerebral Hemorrhage

TLR Signaling in Brain Immunity.

Reduced Cerebral Ischemia-Reperfusion Injury in Toll-like Receptor 4 Deficient Mice.

Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice

Involvement of Toll Like Receptor 2 Signaling in Secondary Injury During Experimental Diffuse Axonal Injury in Rats

Inhibition of TLR4 Signalling-Induced Inflammation Attenuates Secondary Injury after Diffuse Axonal Injury in Rats

Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage.

TLR4 Enhances Cerebral Ischemia/Reperfusion Injury via Regulating NLRP3 Inflammasome and Autophagy

Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury

Potential Medications or Compounds Acting on Toll-like Receptors in Cerebral Ischemia.